共查询到20条相似文献,搜索用时 102 毫秒
1.
2.
《中国生物制品学杂志》2016,(5)
目的饲养、繁殖并鉴定CXC趋化因子配体4[chemokine(C-X-C motif)ligand 4,CXCL4]基因敲除小鼠,为深入研究CXCL4的生物学功能奠定基础。方法将引进的杂合子小鼠进行饲养并繁殖,剪取繁殖成功的子代小鼠耳朵,提取其基因组DNA,采用PCR法鉴定小鼠的基因型;比较野生型小鼠和CXCL4敲除的纯合子小鼠的体重变化及结直肠的长度,通过HE染色观察野生型小鼠和CXCL4敲除的纯合子小鼠的结直肠形态结构;采用ELISA法验证CXCL4野生型和纯合子小鼠血清中CXCL4的表达。结果繁殖成功的子代小鼠有3种基因型:野生型、杂合子及纯合子;4、10周龄雌性纯合子小鼠体重明显重于同龄的野生型小鼠(P0.05),6、10周龄雄性纯合子小鼠体重明显重于同龄的野生型小鼠(P0.05);6周龄雌性纯合子小鼠结直肠长度明显长于同周龄的野生型小鼠(P0.05),但结直肠的形态结构无显著改变;纯合子小鼠血清中CXCL4的表达量明显低于WT小鼠(P0.05)。结论成功获得了CXCL4基因敲除纯合子小鼠,为深入研究CXCL4的生物学功能奠定了基础。 相似文献
3.
基因敲除技术是20世纪80年代发展起来的一种分子生物学技术,目前已广泛应用于微生物基因功能等相关领域的研究中。维氏气单胞菌(Aeromonas veronii,A. veronii)是气单胞菌科气单胞菌属的一种,近年来,该菌引发疾病的报道逐年增多,因此,对其致病机制的研究显得尤为重要。本文对细菌不同基因敲除策略及其在A. veronii基因功能研究中的应用作一综述,旨在为A. veronii致病机制的深入研究提供参考。 相似文献
4.
通过敲除黑曲霉(Aspergillus niger)菌株ATCC1015的苹果酸酶(Malic enzyme,ME)基因,研究了ME基因敲除对黑曲霉TCA循环相关代谢的影响。利用农杆菌(Agrobacterium tumefaciens)介导的转化方法转化黑曲霉,通过同源重组敲除黑曲霉ME基因,筛选ME基因敲除菌株,获得了遗传性能稳定的ME基因敲除菌株。通过发酵实验,对比了野生菌株和ME基因敲除菌株在代谢产物累积方面的差异,发现ME基因敲除菌株的TCA循环中各种有机酸的产量与野生菌株相比没有明显变化。表明,ME基因的敲除对TCA循环没有产生明显影响。 相似文献
5.
Pten敲除对Rad51基因表达的影响及其机制 总被引:1,自引:1,他引:0
目的研究Pten敲除对Rad51基因表达的影响及其可能的机制。方法采用半定量RT-PCR法和克隆形成试验比较Pten+/+MEFs与Pten-/-MEFs两种细胞中同源重组修复相关基因Rad51mRNA转录水平的差异,并比较两种细胞对辐射敏感性的差异和辐射后Rad51基因mRNA转录水平的差异及其可能的机制。结果与Pten+/+MEFs细胞相比,Pten-/-MEFs细胞中Rad51基因mRNA的转录水平和对辐射的敏感性显著降低;辐射后以及PI3K/AKT信号通路抑制剂LY-294002作用后,Rad51基因mRNA的转录水平明显增高。结论Pten缺失后Rad51基因表达异常,Pten可能通过PI3K/AKT信号通路来调控Rad51基因的表达。 相似文献
6.
7.
8.
9.
10.
由于含氮废水的排放和含氮肥料的大量使用,氮污染成为一个日益严重的问题。生物处理的效率高、成本低、对环境友好,是废水脱氮的主要处理技术之一。硫自养反硝化由于不需要额外的碳源、产泥量少等特点而得到广泛关注。文章对单质硫、硫化物、硫代硫化物作为电子供体进行反硝化脱氮的研究进展进行了综述,探讨了硫自养反硝化的代谢途径和影响机制,对几种硫自养反硝化的影响因子进行了概述。在此基础上分析了硫自养反硝化微生物以及nar、nir、nor、nos等几种反硝化功能基因,并对反硝化工艺的发展和联用技术提出展望。 相似文献
11.
低分子量壳聚糖作为非病毒性基因治疗载体有着广阔的前景,已成为研究的热点。综述了低分子量壳聚糖的制备方法以及载基因的研究进展,并讨论了影响转染的因素。 相似文献
12.
13.
14.
15.
16.
Mohube B. Maepa Ilke Roelofse Abdullah Ely Patrick Arbuthnot 《International journal of molecular sciences》2015,16(8):17589-17610
Despite the availability of an effective vaccine against hepatitis B virus (HBV), chronic infection with the virus remains a major global health concern. Current drugs against HBV infection are limited by emergence of resistance and rarely achieve complete viral clearance. This has prompted vigorous research on developing better drugs against chronic HBV infection. Advances in understanding the life cycle of HBV and improvements in gene-disabling technologies have been impressive. This has led to development of better HBV infection models and discovery of new drug candidates. Ideally, a regimen against chronic HBV infection should completely eliminate all viral replicative intermediates, especially covalently closed circular DNA (cccDNA). For the past few decades, nucleic acid-based therapy has emerged as an attractive alternative that may result in complete clearance of HBV in infected patients. Several genetic anti-HBV strategies have been developed. The most studied approaches include the use of antisense oligonucleotides, ribozymes, RNA interference effectors and gene editing tools. This review will summarize recent developments and progress made in the use of gene therapy against HBV. 相似文献
17.
张颖琦 《中国生物制品学杂志》2009,22(3)
动物乳腺生物反应器是利用转基因技术获得药物蛋白的动物个体表达系统,其利用乳腺特异性调控元件指导外源基因在乳腺中特异地表达,以转基因动物的乳腺组织生产药用重组蛋白。本文就动物乳腺生物反应器的操作流程、应用、优点、存在的问题及其国内外研究进展和产业化现状作一综述。 相似文献
18.
Ricardo Afonso-Reis Inês T. Afonso Clvio Nbrega 《International journal of molecular sciences》2021,22(8)
Polyglutamine spinocerebellar ataxias (PolyQ SCAs) are a group of 6 rare autosomal dominant diseases, which arise from an abnormal CAG repeat expansion in the coding region of their causative gene. These neurodegenerative ataxic disorders are characterized by progressive cerebellar degeneration, which translates into progressive ataxia, the main clinical feature, often accompanied by oculomotor deficits and dysarthria. Currently, PolyQ SCAs treatment is limited only to symptomatic mitigation, and no therapy is available to stop or delay the disease progression, which culminates with death. Over the last years, many promising gene therapy approaches were investigated in preclinical studies and could lead to a future treatment to stop or delay the disease development. Here, we summed up the most promising of these therapies, categorizing them in gene augmentation therapy, gene silencing strategies, and gene edition approaches. While several of the reviewed strategies are promising, there is still a gap from the preclinical results obtained and their translation to clinical studies. However, there is an increase in the number of approved gene therapies, as well as a constant development in their safety and efficacy profiles. Thus, it is expected that in a near future some of the promising strategies reviewed here could be tested in a clinical setting and if successful provide hope for SCAs patients. 相似文献
19.
微型化学实验是当今化学教学中的重要变革之一。本文简单介绍了微型化学实验的特点和当前国内外发展的概况,倡议在我省的化学中尽快推行微型化学实验 相似文献